Deficiency in mitochondrial complex i Activity Due to Ndufs6 gene trap insertion induces renal disease

Antioxidants and Redox Signaling

Volumn 19, Issue 4, 2013, Pages 331-343

  Forbes, Josephine M ^a,b,c   Ke, Bi Xia ^d   Nguyen, Tuong Vi ^a   Henstridge, Darren C ^a   Penfold, Sally A ^a   Laskowski, Adrienne ^d   Sourris, Karly C ^a,c   Groschner, Lukas N ^a   Cooper, Mark E ^a,c   Thorburn, David R ^d   Coughlan, Melinda T ^a,c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYSTATIN C; KIDNEY INJURY MOLECULE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE; GENE INSERTION; KIDNEY CORTEX; KIDNEY DISEASE; MITOCHONDRIAL RESPIRATION; MOUSE; NDUFS6 GENE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RISK FACTOR; UPREGULATION; URINARY EXCRETION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; ELECTRON TRANSPORT COMPLEX I; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MITOCHONDRIAL DISEASES; NADH DEHYDROGENASE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

MUS;

EID: 84879855808     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4719     Document Type: Article

References (69)

1. Bakris GL and Ritz E. The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. Kidney Int 75:449-452, 2009.
2. Balaban RS and Mandel LJ. Metabolic substrate utilization by rabbit proximal tubule. An NADH fluorescence study. Am J Physiol 254(3 Pt 2):F407-F416, 1988.
3. Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, Blencowe BJ, and Frey BJ. Deciphering the splicing code. Nature 465:53-59, 2010.
4. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chretien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39:776-780, 2007. (Pubitemid 46848590)
5. Brosius FC, 3rd. New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev Endocr Metab Disord 9:245-254, 2008.
6. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, and Luno J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 111:S4-S9, 2008.
7. Carroll J, Fearnley IM, Skehel JM, Shannon RJ, Hirst J, and Walker JE. Bovine complex I is a complex of 45 different subunits. J Biol Chem 281:32724-32727, 2006. (Pubitemid 46036828)
8. Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, and Toniolo A. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 102:2041-2049, 1998. (Pubitemid 29018810)
9. Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, and Forbes JM. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology 2007;148:886-895. (Pubitemid 46143188)
10. Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan AL, Fukami K, Thallas-Bonke V, Nawroth PP, et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol 20:742-752, 2009.
11. de Lonlay P, Valnot I, Barrientos A, Gorbatyuk M, Tzagoloff A, Taanman JW, Benayoun E, Chretien D, Kadhom N, Lombes A, et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 29:57-60, 2001. (Pubitemid 32801809)
12. Del Vecchio L, Locatelli F, and Carini M. What we know about oxidative stress in patients with chronic kidney disease on dialysis-clinical effects, potential treatment, and prevention. Semin Dial 24:56-64, 2011.
13. Drew B and Leeuwenburgh C. Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction. Am J Physiol Regul Integr Comp Physiol 285:R1259-R1267, 2003. (Pubitemid 37296381)
14. Feeney MB and Schoneich C. Tyrosine modifications in aging. Antioxid Redox Signal 2012;17:1571-1579.
15. Forbes JM, Coughlan MT, and Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 50:1446-1454, 2008.
16. Fukai T and Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15:1583-1606, 2011.
17. Gabaldon T, Rainey D, and Huynen MA. Tracing the evolution of a large protein complex in the eukaryotes, NADH:ubiquinone oxidoreductase (Complex I). J Mol Biol 348:857-870, 2005. (Pubitemid 40544387)
18. Grzegorczyk K, Krajewska M, Weyde W, Jakuszko K, Gniewek A, and Klinger M. [Gender and kidney diseases: the clinical importance and mechanisms of modifying effects]. Postepy Hig Med Dosw (Online) 65:849-857, 2011.
19. Hall AM and Unwin RJ. The not so ''mighty chondrion'': emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol 105:1-10, 2007.
20. Hall AM, Unwin RJ, Hanna MG, and Duchen MR. Renal function and mitochondrial cytopathy (MC): more questions than answers? QJM 101:755-766, 2008.
21. Han WK, Bailly V, Abichandani R, Thadhani R, and Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237-244, 2002. (Pubitemid 34754067)
22. Harris SI, Balaban RS, Barrett L, and Mandel LJ. Mitochondrial respiratory capacity and Na+ -and K+ -dependent adenosine triphosphatase- mediated ion transport in the intact renal cell. J Biol Chem 256:10319-10328, 1981. (Pubitemid 12219425)
23. Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z, Xie LX, Salviati L, Hurd TW, Vega-Warner V, et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013-2024, 2011.
24. Hirst J. Towards the molecular mechanism of respiratory complex I. Biochem J 2010;425:327-339.
25. Ke BX, Pepe S, Grubb DR, Komen JC, Laskowski A, Rodda FA, Hardman BM, Pitt JJ, Ryan MT, Lazarou M, et al. Tissuespecific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy. Proc Natl Acad Sci U S A 109:6165-6170, 2012.
26. Kirby DM, Salemi R, Sugiana C, Ohtake A, Parry L, Bell KM, Kirk EP, Boneh A, Taylor RW, Dahl HH, et al. NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 114:837-845, 2004. (Pubitemid 39578743)
27. Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA, and Willems PH. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal 12: 1431-1470, 2010.
28. Libetta C, Sepe V, Esposito P, Galli F, and Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem 44:1189-1198, 2011.
29. Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, and Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 12:114-121, 2010.
30. Lopez-Novoa JM and Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1:303-314, 2009.
31. Lyon MF and Hulse EV. An inherited kidney disease of mice resembling human nephronophthisis. J MedGenet 8:41-48, 1971.
32. Maric C, Sandberg K, and Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol 15:1546-1556, 2004. (Pubitemid 38679679)
33. Martin-Hernandez E, Garcia-Silva MT, Vara J, Campos Y, Cabello A, Muley R, Del Hoyo P, Martin MA, and Arenas J. Renal pathology in children with mitochondrial diseases. Pediatr Nephrol 20:1299-1305, 2005. (Pubitemid 41226421)
34. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, and Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073-2081, 2010.
35. Mimaki M, Wang X, McKenzie M, Thorburn DR, and Ryan MT. Understanding mitochondrial complex I assembly in health and disease. Biochim Biophys Acta 1817:851-862, 2012.
36. Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G, and Pacher P. Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Commun 358:203-208, 2007. (Pubitemid 46719103)
37. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417:1-13, 2009.
38. Peng M, Falk MJ, Haase VH, King R, Polyak E, Selak M, Yudkoff M, Hancock WW, Meade R, Saiki R, et al. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet 4:e1000061, 2008.
39. Pitkanen S and Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 98:345-351, 1996. (Pubitemid 26255732)
40. Radi R, Rodriguez M, Castro L, and Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308:89-95, 1994. (Pubitemid 24172608)
41. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, Christodoulou J, and Thorburn DR. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343-351, 1996. (Pubitemid 26100758)
42. Rebelo L, Carmo-Fonseca M, and Moura TF. Redistribution of microvilli and membrane enzymes in isolated rat proximal tubule cells. Biol Cell 74:203-209, 1992.
43. Roberts LJ, 2nd and Morrow JD. The generation and actions of isoprostanes. Biochim Biophys Acta 1345:121-135, 1997. (Pubitemid 27138414)
44. Roberts LJ andMorrow JD.Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28: 505-513, 2000.
45. Ross MF, Kelso GF, Blaikie FH, James AM, Cocheme HM, Filipovska A, Da Ros T, Hurd TR, Smith RA, and Murphy MP. Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Mosc) 70:222-230, 2005. (Pubitemid 40512331)
46. Rotig A. Renal disease and mitochondrial genetics. J Nephrol 16:286-292, 2003. (Pubitemid 37304088)
47. Rotig A, Goutieres F, Niaudet P, Rustin P, Chretien D, Guest G, Mikol J, Gubler MC, and Munnich A. Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr 126:597-601, 1995.
48. Rotig A and Munnich A. Genetic features of mitochondrial respiratory chain disorders. J Am Soc Nephrol 14:2995-3007, 2003. (Pubitemid 37509278)
49. Saito T, Sumithran E, Glasgow EF, and Atkins RC. The enhancement of aminonucleoside nephrosis by the coadministration of protamine. Kidney Int 32:691-699, 1987. (Pubitemid 17152399)
50. Sandberg K. Mechanisms underlying sex differences in progressive renal disease. Gend Med 5:10-23, 2008. (Pubitemid 351506543)
51. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154-2169, 2003. (Pubitemid 37337595)
52. Sen CK and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720, 1996. (Pubitemid 26172817)
53. Silbiger S and Neugarten J. Gender and human chronic renal disease. Gend Med 5 Suppl A:S3-S10, 2008. (Pubitemid 351455227)
54. Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126(Pt 8):1905-1912, 2003. (Pubitemid 36917349)
55. Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K, Penfold SA, Coughlan MT, Cooper ME, Nguyen TV, Ritchie RH, et al. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med 52:716-723, 2012.
56. Spiegel R, Shaag A, Mandel H, Reich D, Penyakov M, Hujeirat Y, Saada A, Elpeleg O, and Shalev SA. Mutated NDUFS6 is the cause of fatal neonatal lactic acidemia in Caucasus Jews. Eur J Hum Genet 17:1200-1203, 2009.
57. Srere PA. Citrate Synthase (EC4.1.3.7). In: Methods in Enzymology Volume 13, edited by Lowenstein JM. New York: Academic press, 1969, pp. 3-10.
58. Szabolcs MJ, Seigle R, Shanske S, Bonilla E, DiMauro S, and D'Agati V. Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kidney Int 45:1388-1396, 1994. (Pubitemid 24135025)
59. Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O'Brien RC, Bierhaus A, Cooper ME, et al. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol 298:F763-F770, 2010.
60. Thorburn DR, Chow CW, and Kirby DM. Respiratory chain enzyme analysis in muscle and liver. Mitochondrion 4: 363-375, 2004. (Pubitemid 39646790)
61. Tucker EJ, Compton AG, Calvo SE, and Thorburn DR. The molecular basis of human complex I deficiency. IUBMB Life 63:669-677, 2011.
62. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28:478-485, 2010.
63. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, and Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290:F517-F529, 2006. (Pubitemid 43725006)
64. Valnot I, von Kleist-Retzow JC, Barrientos A, Gorbatyuk M, Taanman JW, Mehaye B, Rustin P, Tzagoloff A, Munnich A, and Rotig A. A mutation in the human heme A:farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum Mol Genet 9:1245-1249, 2000. (Pubitemid 30248611)
65. Weibel ER and Gomez DM. A principle for counting tissue structures on random sections. J Appl Physiol 17:343-348, 1962.
66. Wendel U, Ruitenbeek W, Bentlage HA, Sengers RC, and Trijbels JM. Neonatal De Toni-Debre-Fanconi syndrome due to a defect in complex III of the respiratory chain. Eur J Pediatr 154:915-918, 1995.
67. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, and Zhou BP. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416-428, 2009.
68. Yaplito-Lee J, Weintraub R, Jamsen K, Chow CW, Thorburn DR, and Boneh A. Cardiac manifestations in oxidative phosphorylation disorders of childhood. J Pediatr 150:407-411, 2007. (Pubitemid 46428309)
69. Zielonka J and Kalyanaraman B. Hydroethidine-and Mito-SOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med 48:983-1001, 2010.